Equillium (EQ) EBITDA (2018 - 2026)

Equillium (EQ) has 9 years of EBITDA data on file, last reported at -$5.6 million in Q1 2026.

• On a quarterly basis, EBITDA rose 36.75% year-over-year to -$5.6 million in Q1 2026; TTM through Mar 2026 was -$20.4 million, a 42.02% decrease from a year earlier, with the FY2025 full-year figure at -$23.6 million, down 185.81% from the prior year.
• EBITDA for Q1 2026 stood at -$5.6 million, down from -$4.0 million in the prior quarter.
• Over the last five years, EBITDA for EQ reached as high as $2.0 million in Q4 2022 and fell as low as -$37.3 million in Q1 2022.
• Historically, EBITDA has averaged -$6.7 million across 5 years, with a median of -$4.1 million in 2023.
• Across the five-year window, EBITDA soared 119.66% in 2022 and sank 6128.0% in 2025, its largest moves.
• Year by year, EBITDA stood at $2.0 million in 2022, then plunged by 256.71% to -$3.2 million in 2023, then slumped by 46.81% to -$4.7 million in 2024, then climbed by 15.67% to -$4.0 million in 2025, then sank by 41.6% to -$5.6 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were -$5.6 million in Q1 2026, -$4.0 million in Q4 2025, and -$4.6 million in Q3 2025.